EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
Crossref DOI link: https://doi.org/10.1186/1129-2377-15-S1-E24
Published Online: 2014-09-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cernuda-Morollón, E
Martínez-Camblor, P
Serrano-Pertierra, E
Larrosa, D
Ramón, C
Pascual, J
License valid from 2014-09-18